Pacific
-
Pharmaceutical companies from Japan, India and China are amongst Asia Pacific’s most innovative
Pharmaceutical companies from Japan, India and China were among Asia Pacific’s leading innovators last year according to one of two reports released by Thomson Reuters, which provide new insights into global patent and trademark trends throughout 2011.
Pacific | 28 March 2012
-
ICON Development Solutions appoints general manager of Asia Pacific
ICON announced that its development solutions division has appointed Dr Daniel Tang as general manager, Asia Pacific. Dr Tang will lead the development of ICON’s early phase activities across the region, including bioanalytical laboratory services, and the development of strong links with key opinion leaders for early phase clinical testing.
Pacific | 12 December 2011
-
Bio-Images Group expands its presence in Asia Pacific
To exhibit at AusBiotech 2011 in Adelaide, South Australia this October.
Pacific | 10 October 2011
-
India generics companies lead pharmaceutical innovation in Asia Pacific
Thomson Reuters Asia Pacific R&D Factbook details significant increases in innovation investment and development of novel drug pipelines.
Pacific | 30 September 2011
-
Almac adds depots for clinical trial supply distribution to Asia Pacific
Almac's Clinical Services business unit has increased its presence in the Asia Pacific region. Its reach has been extended by adding five new depots located in Japan, Thailand, Hong Kong, and Taiwan to its extensive global depot network. These latest…
Pacific | 01 July 2011
-
Almac adds depots for clinical trial supply distribution to Asia Pacific
Almac’s Clinical Services business unit has increased its presence in the Asia Pacific region. Its reach has been extended by adding five new depots located in - Japan, Thailand, Hong Kong, and Taiwan to its extensive global depot network. These la…
Pacific | 01 July 2011
-
ICON announces Asia Pacific seminar series
First series to focus on oncology trials.
Pacific | 16 June 2011
-
Nycomed to market Roche's osteoporosis treatment in Asia Pacific
Nycomed announced that it has completed the transfer of marketing authorization approvals in a number of key Asia Pacific markets for osteoporosis treatment Bonviva (Ibandronate). According to the company, the licensing agreement with Roche marks a f…
Pacific | 15 June 2011
-
ICON continues Asia Pacific expansion with new office opening in Shanghai
ICON has opened a new office in Shanghai, China, and is also relocating its Beijing operations to larger premises. In addition, ICON has announced the appointment Dr Malcolm Burgess, to the position of Executive Vice President, Asia Pacific, and Paul…
Pacific | 29 March 2011
-
Pharma enhances its focus on Asia-Pacific partnerships
Datamonitor ’s report “Pharmaceutical Licensing and Alliances in the Asia-Pacific Regionâ€, published in November 2010, reveals that pharma is enhancing its focus on markets in the APAC region. The largest of the developed APAC markets, Jap…
Pacific | 24 November 2010
